Intra-articular Injection of Platelet-rich Plasma vs. Local Anesthetic with Steroid to Treat Knee Osteoarthritis: A Prospective Randomized Controlled Study
Citation Information :
Kotekar N, Matche P, H K, Gaddam N. Intra-articular Injection of Platelet-rich Plasma vs. Local Anesthetic with Steroid to Treat Knee Osteoarthritis: A Prospective Randomized Controlled Study. J Recent Adv Pain 2018; 4 (3):91-95.
Introduction: Osteoarthritis (OA) of the knee is a prevailing, chronic degenerative condition that generates a high expense. Alternative and adjuvant therapies are currently being foraged to improve the physical function and quality of life of affected patients. Intraarticular (IA) corticosteroid injection provides a short-term reduction in OA knee pain. Platelet-rich plasma (PRP) is now an emerging modality for OA knee, but there is still a lack of clinical evidence.
Aim: To evaluate the clinical effectiveness of knee IA injection of corticosteroid + local anesthetic (LA) with that of autologous PRP using standard scoring systems. To assess the degree of pain relief, improvement in range of motion of the knee joint and incidence of adverse effects.
Materials and methods: Sixty-four patients selected according to the inclusion criteria were treated with two IA injections given 4 weeks. All patients were divided into two groups–group P and S. Thirty two patients in group P were treated with PRP and 32-patients in group S with LA + Steroid. All patients were prospectively evaluated at the pain clinic and 3 and 6 months after the treatment for the following parameters: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, index of severity for knee osteoarthritis (ISK) score by Lequesne et al., visual analog score (VAS) score and range of motion of knee. Adverse events were also chronicled.
Results: There was an improvement in both the groups at 3 months, but there was no statistically significant difference between the ISK scores, MWI scores, and ROM whereas VAS score in group S was significantly lower than group P (p value = 0.03). At 6 months follow-up, the mean VAS score, the ISK scores, MWI scores and ROM in the group P were significantly lower than group S (p value = 0.0001; 0.0001; 0.003; 0.001). No significant complications related to injection were observed during the treatment and follow-up.
Conclusion: Improvement in the knee function was better with PRP than steroid group at short term follow-up. PRP is safe and more effective than steroids in alleviating pain in symptomatic OA knee.
Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010;26(3):355-369.
Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best practice and research Clinical rheumatology. 2008 Apr 1;22(2):351-384.
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumat ology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465-474.
Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthrosc J Arthrosc Relat Surg. 2012;28(3):429-439.
Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009;17(2):153-162.
Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1145-1153.
Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-Art management of knee osteoarthritis. World J Clin Cases WJCC. 2015;3(2):89.
Dhillon MS, Patel S, John R. PRP in OA knee–update, current confusions and future options. SICOT-J. 2017;3.
Chou CL, Lee SH, Lu SY, Tsai KL, Ho CY, Lai HC. Therapeutic effects of intra-articular botulinum neurotoxin in advanced knee osteoarthritis. J Chin Med Assoc. 2010 Nov. 73(11): 573-580.
Conti F, Priori R, Chimenti MS, Coari G, Annovazzi A, Valesini G, et al. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTcinfliximab. Arthritis Rheum 2005 Apr;52(4):1224-1226.
Two New Intra-Articular Injections for Knee Osteoarthritis. JAMA. 2018;320(21):2262-2263.
Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351.
Raeissadat S, Rayegani S, Babaee M, Ghorbani E. The Effect of Platelet-Rich Plasma on Pain, Function, and Quality of Life of Patients with Knee Osteoarthritis. Pain Research and Treatment. 2013;2013:1-7.
Arden NK, Reading IC, Jordan KM, Thomas L, Platten H, Hassan A, et al. A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS Study. Osteoarthritis Cartilage. 2008;16(6): 733-739.
Chao J, Wu C, Sun B, Hose MK, Quan A, Hughes TH, et al. Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis. J Rheumatol. 2010;37(3):650-655.
Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J. Safety and efficacy of longterm intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2003;48(2):370-377.
Beyaz SG. Comparison of efficacy of intra-articular morphine and steroid in patients with knee osteoarthritis. J Anaesthesiol Clin Pharmacol. 2012 Oct;28(4):496-500.
Hepper CT, Halvorson JJ, Duncan ST, Gregory AJ, Dunn WR, Spindler KP. The Efficacy and Duration of Intraarticular Corticosteroid Injection for Knee Osteoarthritis: A Systematic Review of Level I Studies. J Am Acad Orthop Surg. 2009;17(10):638-646.
Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Arthritis Care Res. 2009;61(12):1704-1711.
Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. Bmj. 2004;328(7444):869.
Sánchez M, Anitua E, Orive G, Mujika I, Andia I. Plateletrich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39(5):345-354.
Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil. 2010;89(12):961-969.
Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):472-479.
Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411-417.
Say F, Gürler D, Yener K, Bülbül M, Malkoc M. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech. 2013;80(4):278-283.
Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356-364.
Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee shortterm effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131(3):311–317.
Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13(1):229.
Rayegani SM, Raeissadat SA, Taheri MS, Babaee M, Bahrami MH, Eliaspour D, et al. Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trial. Orthop Rev. 2014;6(3).